Phase II study of amikacin for treatment of non-tuberculous mycobacterium infection.

Trial Profile

Phase II study of amikacin for treatment of non-tuberculous mycobacterium infection.

Planning
Phase of Trial: Phase II

Latest Information Update: 15 Nov 2017

At a glance

  • Drugs Amikacin (Primary)
  • Indications Mycobacterial infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Nov 2017 According to a Matinas BioPharma media release, the company expects to initiate this study in Q4 2018.
    • 11 Aug 2017 New trial record
    • 08 Aug 2017 According to a Matinas BioPharma media release, the company plans to initiate phase II NTM study in second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top